These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 10480671
1. The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms. Sharma RP, Singh V, Janicak PG, Javaid JI, Pandey GN. Schizophr Res; 1999 Aug 23; 39(1):85-9. PubMed ID: 10480671 [Abstract] [Full Text] [Related]
2. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia. Mohr P, Horácek J, Motlová L, Libiger J, Czobor P. Schizophr Res; 1998 Feb 27; 30(1):91-9. PubMed ID: 9542792 [Abstract] [Full Text] [Related]
3. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study. Monteleone P, Tortorella A, Borriello R, Cassandro P, Maj M. Biol Psychiatry; 1999 Jun 15; 45(12):1606-11. PubMed ID: 10376122 [Abstract] [Full Text] [Related]
4. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol. Mulder RT, Porter RJ, Joyce PR. J Psychopharmacol; 2003 Mar 15; 17(1):97-102. PubMed ID: 12680745 [Abstract] [Full Text] [Related]
5. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine. Park SB, Williamson DJ, Cowen PJ. Psychol Med; 1996 Nov 15; 26(6):1191-6. PubMed ID: 8931165 [Abstract] [Full Text] [Related]
7. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients. Abel KM, O'Keane V, Murray RM. Br J Psychiatry; 1996 Jan 15; 168(1):57-60. PubMed ID: 8770429 [Abstract] [Full Text] [Related]
8. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test. Rajewska J, Rybakowski JK. Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun 15; 27(4):705-9. PubMed ID: 12787860 [Abstract] [Full Text] [Related]
11. Effects of haloperidol treatment on prolactin response to D-fenfluramine challenge in acute schizophrenia. Mohr P, Horácek J, Motlová L, Libiger J, Czobor P. Psychopharmacology (Berl); 1999 Jan 15; 141(3):322-5. PubMed ID: 10027514 [Abstract] [Full Text] [Related]
12. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects. Gorard DA, Taylor TM, Medbak SH, Perry LA, Libby GW, Farthing MJ. Int Clin Psychopharmacol; 1993 Jan 15; 8(2):123-8. PubMed ID: 8393895 [Abstract] [Full Text] [Related]
13. Hormonal responses to fenfluramine in depressive subtypes. Mitchell P, Smythe G, Parker G, Wilhelm K, Hickie I, Brodaty H, Boyce P. Br J Psychiatry; 1990 Oct 15; 157():551-7. PubMed ID: 2131137 [Abstract] [Full Text] [Related]
14. The fenfluramine challenge test in the affective spectrum: a possible marker of endogeneity and severity. López-Ibor JJ, Saiz-Ruiz J, Iglesias LM. Pharmacopsychiatry; 1988 Jan 15; 21(1):9-14. PubMed ID: 3283785 [Abstract] [Full Text] [Related]
15. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder. McBride PA, DeMeo MD, Sweeney JA, Halper J, Mann JJ, Shear MK. Biol Psychiatry; 1992 Jan 01; 31(1):19-34. PubMed ID: 1311964 [Abstract] [Full Text] [Related]
16. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Malone KM, Corbitt EM, Li S, Mann JJ. Br J Psychiatry; 1996 Mar 01; 168(3):324-9. PubMed ID: 8833686 [Abstract] [Full Text] [Related]
18. Endocrine and amine responses to D,L-fenfluramine in normal subjects. Mitchell PB, Smythe GA. Psychiatry Res; 1991 Nov 01; 39(2):141-53. PubMed ID: 1686811 [Abstract] [Full Text] [Related]
19. Serotonergic regulation of prolactin and growth hormone secretion in man. Lewis DA, Sherman BM. Acta Endocrinol (Copenh); 1985 Oct 01; 110(2):152-7. PubMed ID: 4060968 [Abstract] [Full Text] [Related]
20. Oral D-fenfluramine and neuroendocrine challenge: problems with the 30 mg dose in men. Goodwin GM, Murray CL, Bancroft J. J Affect Disord; 1994 Feb 01; 30(2):117-22. PubMed ID: 8201126 [Abstract] [Full Text] [Related] Page: [Next] [New Search]